Comparison tool
Snap-8 vs GHK-Cu side-by-side
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Comparison tool
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Selected (2/4)
Share this peptide comparison
| Property | Snap-8 | GHK-Cu |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| Also known as | Acetyl Octapeptide-3, SNAP-8 | Copper Peptide, Glycyl-L-histidyl-L-lysine copper |
| FDA approved | No | No |
| Clinical status | Cosmetic skincare ingredient; widely available in skincare products
| Used in cosmetic products with limited human topical-skincare evidence; the source also notes injectable compounding restrictions and a pending reclassification process.
|
| What to expect | Wrinkle reduction, expression lines, anti-aging skincare | Skin rejuvenation, wound healing, hair growth, anti-aging |
| How it works | Snap-8 is proposed to act as a SNAP-25-mimicking cosmetic peptide that may disrupt steps in SNARE-complex signaling linked to acetylcholine release. The source presents this as a plausible mechanism based on sequence-related rationale and nonclinical work, while noting that delivery through skin and confirmation of muscle-level effects after topical use remain uncertain. | GHK-Cu is described as the copper(II) complex of the GHK tripeptide. The source connects its activity to copper binding and possible cellular copper delivery, but also emphasizes effects that go beyond a simple carrier model. Reported laboratory observations include shifts in gene expression, increased fibroblast production of extracellular-matrix components, keratinocyte support, vascular-related activity, and antioxidant or anti-inflammatory signals. The precise mechanism is still not fully defined. |
| Typical dosing | Limited community data available · See research protocols | 1-2 mg daily injection or 0.05% topical · Once daily · Subcutaneous injection or topical application |
| Research dosing | 3-10% in topical formulations · Ongoing use for maintained effects · Topical (serums, creams) | 1-2 mg for injectable protocols · Varies by application · Subcutaneous injection or topical application |
| Typical duration | Ongoing use for maintained effects | Varies by application |
| Administration | Topical (serums, creams) | Subcutaneous injection or topical application |
| Timing | Evening (topical) No food-related timing issue is identified for topical use; source lists with or without food. | Evening for skin or recovery contexts With or without food |
| Evidence level | Research | Clinical Trials |
| Possible side effects |
+1 more
|
+4 more
|
| Research summary | The source characterizes SNAP-8-specific human evidence as limited and heavily dependent on manufacturer-linked material. It compares the evidence landscape with Argireline, where reported wrinkle-depth improvements in one early study are contrasted with later split-face findings that did not show a statistically significant peptide-placebo difference. The source also highlights unresolved questions about topical penetration and whether the proposed muscle-inhibition mechanism has been demonstrated in living tissue. | The source describes a mixed evidence base. Cell and animal work is reported for wound repair, collagen deposition, fibroblast activity, elastin and growth-factor production, keratinocyte protection, and lung-injury models. Human data are described as small topical cosmetic studies, including facial-cream and eye-cream studies with 71 and 41 participants that reported changes in skin density, thickness, and wrinkle appearance. These data are encouraging for topical skin endpoints but do not establish injected or systemic benefits. |
| References | ||
| Full profile | View Details | View Details |
Save this comparison
Keep this research set handy with a free PeptiGuide account.
Save this comparison - free accountTrack your peptide journey
Turn research into a private protocol log when you are ready.
Track your peptide journeyEducational use only. This information is aggregated from public research and community reports. It is not medical advice, and dosing details are descriptive, not recommendations. Always consult a qualified healthcare professional.